CareDx, Inc (CDNA)
$63.12-0.86%Close
BUYBULL · day 95
Key stats
Short interest · FINRA settlement 2026-09-30
- Market cap
- $3.3B
- Beta
- 2.38
- P/E (TTM)
- 29.64
- Short % float
- 13.37%
- Days to cover
- 4.6
- SI change
- +4.6%
- 1W
- -9.63%
- 1M
- +25.59%
- vs SPY 1W
- -10.06%
- vs SPY 1M
- +23.53%
Industry peers
FMP comparable companies · ranked by market cap
- NTRABUYNatera, Inc.$57.4BBULLQ 30$400.65-0.73%
- QGENBUYQiagen N.V.$9.4BRECOVERYQ 16$45.65-0.15%
- BLLNSELLBillionToOne, Inc.$4.6BCRISISQ -10$99.94-5.12%
- VCYTBUYVeracyte, Inc.$3.6BBEARQ 14$44.65-2.68%
- WGSSELLGeneDx Holdings Corp.$2.1BCRISISQ -4$71.52-5.21%
- FLGTBUYFulgent Genetics, Inc.$584MRECOVERYQ 13$20.58-1.24%
Prediction markets
Kalshi · Polymarket · … linked
Loading markets…
Company news
FAQ
- What is LOPJLB’s current signal on CDNA?
- LOPJLB’s latest quantitative signal on CareDx, Inc (CDNA) is BUY in a BULL regime. Signals are updated daily.
- What market regime is CDNA in?
- CareDx, Inc (CDNA) is currently classified in the BULL HMM market regime on LOPJLB.
- What does CareDx, Inc (CDNA) do?
- CareDx, Inc. is a global innovator specializing in the discovery, development, and commercialization of diagnostic and management tools designed for transplant recipients and their healthcare providers. The company's extensive portfolio features a range of specialized diagnostic solutions for organ monitoring, including: AlloSure Kidney, AlloSure Heart, and AlloSure Lung: Advanced tests employi…